็›้…ธ็พŸ่€ƒ้…ฎ่ƒถๅ›Š่ƒถๅ›Šๅ‰‚ 10mg

ืžื“ื™ื ื”: ืกื™ืŸ

ืฉืคื”: ืกื™ื ื™ืช

ืžืงื•ืจ: CFDA (่ฏ็›‘ๅฑ€ - ไธญๅ›ฝ้ฃŸๅ“ๅ’Œ่ฏ็‰ฉ็ฎก็†ๅฑ€)

ืงื ื” ืืช ื–ื”

ืžืจื›ื™ื‘ ืคืขื™ืœ:

็›้…ธ็พŸ่€ƒ้…ฎ

ื–ืžื™ืŸ ืž:

NAPP PHARMACEUTICALS LIMITED

ืงื•ื“ ATC:

N02AA05

INN (ืฉื ื‘ื™ื ืœืื•ืžื™):

Oxycodone Hydrochloride

ื›ืžื•ืช:

10mg

ื˜ื•ืคืก ืคืจืฆื‘ื˜ื™ื•ืช:

่ƒถๅ›Šๅ‰‚

ืžืกืœื•ืœ ื ืชื™ื ื” (ืฉืœ ืชืจื•ืคื•ืช):

ๅฃๆœ

ืชื•ืฆืจืช:

BARD PHARMACEUTICALS LIMITED

leaflet_short:

ๆ”ถๅฝ•็ฑปๅˆซ: ่ฟ›ๅฃๅŽŸ็ ”่ฏๅ“

ืžืฆื‘ ืื™ืฉื•ืจ:

ไธŠๅธ‚้”€ๅ”ฎไธญ

ืชืืจื™ืš ืื™ืฉื•ืจ:

2018-07-24

ื—ื™ืคื•ืฉ ื”ืชืจืื•ืช ื”ืงืฉื•ืจื•ืช ืœืžื•ืฆืจ ื–ื”